Management of Biochemical Recurrence in Prostate Cancer
Management of biochemical recurrence in prostate cancer
Speakers: B. Danielson, A Kokorovic, C. Catton, S. Malone
- Define biochemical recurrence (BCR) in prostate cancer
- Identify patients who should be considered for local salvage therapy
- Discuss the optimal timing and duration of androgen-deprivation therapy (ADT)
This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by CUA. You may claim a maximum of 1 hour of credit.
This program has received financial support from Tolmar in the form of an educational grant.